cbdMD (YCBD) Liabilities from Discontinued Operations (2018)
cbdMD (YCBD) posted Liabilities from Discontinued Operations of 7502.0 for Q3 2018.
cbdMD (YCBD) Liabilities from Discontinued Operations (2018) Analysis & Trends
cbdMD has reported Liabilities from Discontinued Operations for 1 years, with the latest figure at 7502.0 in Q3 2018.
- Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 7502.0 in Q3 2018, while the trailing twelve-month figure through Sep 2018 was 7502.0 (changed N/A YoY) and the FY2018 annual result came in at 7502.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations steadied at 7502.0 in Q3 2018 per YCBD's latest filing.
- Over five years, Liabilities from Discontinued Operations peaked at 7502.0 in Q3 2018 and troughed at 7502.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 7,502.00 |
| Sep 30, 2018 | 7,502.00 |